Lutetium [177Lu]-FAP-75

N/A

Report date: 2025/09/19 16:47:30
NME

Base Information

Drug NameLutetium [177Lu]-FAP-75
Drug Alias NameLutetium [177Lu]-FAP-75
ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radionuclide Drug Conjugates
Mechanisms of ActionFibroblast activation protein alpha modulatorsPositron-emission tomography enhancers
TargetsProlyl endopeptidase FAP
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesFudan University
China Registration ClassN/A

Develop Information

Active CompaniesFudan University
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A